|
IT1278077B1
(it)
|
1995-05-25 |
1997-11-17 |
Angeletti P Ist Richerche Bio |
Metodologia per riprodurre in vitro le attivita' di rna polimerasi rna-dipendente e di nucleotidiltransferasi terminale codificate dal
|
|
FR2761695B1
(fr)
|
1997-04-04 |
1999-09-24 |
Bio Merieux |
Arn polymerase fonctionnant preferentiellement sur matrice d'arn, sa preparation et son utilisation
|
|
US6228576B1
(en)
|
1997-12-11 |
2001-05-08 |
Smithkline Beecham Corporation |
Hepatitis C virus NS5B truncated protein and methods thereof to identify antiviral compounds
|
|
KR100719606B1
(ko)
|
1998-02-25 |
2007-05-17 |
에모리 유니버시티 |
2'-플루오로뉴클레오사이드
|
|
JP2002510509A
(ja)
*
|
1998-04-02 |
2002-04-09 |
バイロファーマ・インコーポレイテッド |
Ｃ型肝炎ウイルスｎｓ５ｂ組成物およびその使用方法
|
|
WO1999067396A1
(en)
*
|
1998-06-24 |
1999-12-29 |
International Reagents Corporation |
Hcv-derived rna polymerase gene
|
|
AU2181800A
(en)
*
|
1998-12-10 |
2000-06-26 |
Eli Lilly And Company |
Primer-independent rna synthesis catalyzed by hcv polymerase
|
|
EP1600452A3
(en)
|
1999-11-12 |
2008-09-10 |
Pharmasset, Inc. |
Synthesis of 2'-deoxy-L-nucleosides
|
|
US7018796B2
(en)
*
|
2000-04-07 |
2006-03-28 |
Shionogi & Co., Ltd. |
Preincubation assay methods
|
|
MY164523A
(en)
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
|
KR20080021797A
(ko)
|
2000-05-26 |
2008-03-07 |
이데닉스(케이만)리미티드 |
플라비바이러스 및 페스티바이러스의 치료방법 및 조성물
|
|
GB0029539D0
(en)
*
|
2000-12-04 |
2001-01-17 |
Isis Innovation |
Method for identifying modulatorss of transcription
|
|
IL156457A0
(en)
*
|
2001-01-31 |
2004-01-04 |
Bristol Myers Squibb Pharma Co |
An in-vitro method for genomic replication
|
|
JP4338402B2
(ja)
*
|
2001-05-22 |
2009-10-07 |
ユニバーシティ オブ シカゴ |
Ｎ４ウイルス一本鎖ｄｎａ依存的ｒｎａポリメラーゼ
|
|
CA2460819A1
(en)
*
|
2001-09-18 |
2003-03-27 |
Affinium Pharmaceuticals, Inc. |
Methods and apparatuses for purification
|
|
US20030104445A1
(en)
*
|
2001-09-25 |
2003-06-05 |
Hayes Robert J. |
RNA dependent RNA polymerase mediated protein evolution
|
|
AU2002330154A1
(en)
|
2001-09-28 |
2003-04-07 |
Centre National De La Recherche Scientifique |
Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides
|
|
KR100447578B1
(ko)
*
|
2001-11-01 |
2004-09-07 |
주식회사 이매진 |
Ｈｃｖ 자가 복제 효소 활성의 세포내 측정용 키트 및측정 방법
|
|
WO2003044168A2
(en)
*
|
2001-11-16 |
2003-05-30 |
University Of Massachusetts |
Facilitation of rna interference
|
|
BR0312271A
(pt)
|
2002-06-28 |
2007-11-06 |
Idenix Cayman Ltd |
compostos, composições e seus usos para o tratamento de infecções por flaviviridae
|
|
US7608600B2
(en)
|
2002-06-28 |
2009-10-27 |
Idenix Pharmaceuticals, Inc. |
Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
|
|
HUE033832T2
(en)
|
2002-11-15 |
2018-01-29 |
Idenix Pharmaceuticals Llc |
2'-methyl nucleosides in combination with interferon and Flaviviridae mutation
|
|
EP2345657A1
(en)
|
2003-05-30 |
2011-07-20 |
Pharmasset, Inc. |
Modified fluorinated nucleoside analogues
|
|
EP1658302B1
(en)
|
2003-07-25 |
2010-08-25 |
IDENIX Pharmaceuticals, Inc. |
Purine nucleoside analogues for treating diseases caused by flaviviridae including hepatitis c
|
|
WO2005070957A1
(en)
*
|
2004-01-09 |
2005-08-04 |
Merck & Co., Inc. |
Hcv rna-dependent rna polymerase
|
|
WO2006121468A1
(en)
|
2004-11-22 |
2006-11-16 |
Genelabs Technologies, Inc. |
5-nitro-nucleoside compounds for treating viral infections
|
|
HRP20070436A2
(hr)
|
2005-02-28 |
2008-02-29 |
Genelabs Technologies |
Triciklički nukleozidni predlijekovi za liječenjevirusnih infekcija
|
|
AR056327A1
(es)
|
2005-04-25 |
2007-10-03 |
Genelabs Tech Inc |
Compuestos de nucleosidos para el tratamiento de infecciones virales
|
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
|
US20090318380A1
(en)
|
2007-11-20 |
2009-12-24 |
Pharmasset, Inc. |
2',4'-substituted nucleosides as antiviral agents
|
|
KR20110065440A
(ko)
|
2008-07-02 |
2011-06-15 |
아이데닉스 파마슈티칼스, 인코포레이티드 |
바이러스 감염의 치료를 위한 화합물 및 제약 조성물
|
|
EP2166016A1
(en)
|
2008-09-18 |
2010-03-24 |
Centocor Ortho Biotech Products L.P. |
Phosphoramidate Derivatives of Nucleosides
|
|
PT2376088T
(pt)
|
2008-12-23 |
2017-05-02 |
Gilead Pharmasset Llc |
Fosforamidatos de nucleósidos de 2-amino-purina 6-osubstituída
|
|
KR20110098849A
(ko)
|
2008-12-23 |
2011-09-01 |
파마셋 인코포레이티드 |
뉴클레오시드 유사체
|
|
SG194404A1
(en)
|
2008-12-23 |
2013-11-29 |
Gilead Pharmasset Llc |
Synthesis of purine nucleosides
|
|
US8618076B2
(en)
|
2009-05-20 |
2013-12-31 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
|
TWI598358B
(zh)
|
2009-05-20 |
2017-09-11 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
|
WO2011023801A1
(en)
|
2009-08-31 |
2011-03-03 |
F. Hoffmann-La Roche Ag |
Hcv ns3/4a replicon shuttle vectors
|
|
MX2012005528A
(es)
|
2009-11-14 |
2012-06-12 |
Hoffmann La Roche |
Biomarcadores para pronosticar rapida respuesta a tratamiento hcv.
|
|
MX2012005703A
(es)
|
2009-12-02 |
2012-06-12 |
Hoffmann La Roche |
Biomarcadores para pronosticar una respuesta prolongada al tratamiento contra el vhc.
|
|
US20110245328A1
(en)
|
2010-03-31 |
2011-10-06 |
Hyunsoon Kang |
HCV NS5A Replicon Shuttle Vectors
|
|
PT2609923T
(pt)
|
2010-03-31 |
2017-08-30 |
Gilead Pharmasset Llc |
Processo para a cristalização de 2-(((s)- (perfluorofenoxi)(fenoxi)fosforil)amino)propanoato de (s)-isopropilo
|
|
UY33312A
(es)
|
2010-03-31 |
2011-10-31 |
Pharmasset Inc |
Fosforamidato de nucleosido de purina
|
|
MX2012011222A
(es)
|
2010-04-01 |
2013-01-18 |
Centre Nat Rech Scient |
Compuestos y composiciones farmaceuticas para el tratamiento de infecciones virales.
|
|
AR082453A1
(es)
|
2010-04-21 |
2012-12-12 |
Novartis Ag |
Compuestos de furopiridina, composiciones farmaceuticas que los contienen y usos de los mismos
|
|
EP2595983A1
(en)
|
2010-07-22 |
2013-05-29 |
Novartis AG |
2,3,5-trisubstituted thiophene compounds and uses thereof
|
|
AU2011336632B2
(en)
|
2010-11-30 |
2015-09-03 |
Gilead Pharmasset Llc |
Compounds
|
|
US9351989B2
(en)
|
2010-12-29 |
2016-05-31 |
Inhibitex, Inc. |
Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections
|
|
EP2691409B1
(en)
|
2011-03-31 |
2018-02-21 |
Idenix Pharmaceuticals LLC. |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
|
TW201329096A
(zh)
|
2011-09-12 |
2013-07-16 |
Idenix Pharmaceuticals Inc |
經取代羰氧基甲基磷酸醯胺化合物及用於治療病毒感染之藥學組成物
|
|
EP2755985B1
(en)
|
2011-09-12 |
2017-11-01 |
Idenix Pharmaceuticals LLC |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
|
US8507460B2
(en)
|
2011-10-14 |
2013-08-13 |
Idenix Pharmaceuticals, Inc. |
Substituted 3′,5′-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections
|
|
US8889159B2
(en)
|
2011-11-29 |
2014-11-18 |
Gilead Pharmasset Llc |
Compositions and methods for treating hepatitis C virus
|
|
EA201690473A1
(ru)
|
2013-08-27 |
2017-03-31 |
ГАЙЛИД ФАРМАССЕТ ЭлЭлСи |
Комбинированный состав двух противовирусных соединений
|